0
0
9/29/23 at 7:06am
Organization
Pharmaceutical Technology
Author
RanjithKumar Dharma
30 words
0
Comments
Fabre-Kramer has obtained approval from the US FDA for Exxua to treat major depressive disorder (MDD) in adult patients.
You are the first to view
http://www.pharmaceutical-technology.com/news/fabre-kramer-depressive-disorder-therapy/
Create an account
or login to join the discussion